Shabbir Alibhai, MSc, MD, FRCPC

Our team focuses on clinical and health services research in cancer in older adults (geriatric oncology). The major disease we study is prostate cancer. We also study ways to improve cancer care in vulnerable/complex older adults. Our major projects include:

1) Examining the side effects of treatment in advanced prostate cancer, including androgen deprivation therapy (hormone therapy), chemotherapy, and Radium 223. We examine a variety of toxicities and health outcomes including quality of life, physical function, cognition, and falls.

2) Clinical trials examining the role of exercise in men with prostate cancer on androgen deprivation therapy to improve quality of life, fatigue, and physical fitness.

3) Understanding the value of geriatric assessment in older patients with cancer using both randomized trials (the 5C trial) and knowledge translation approaches in the Older Adults with Cancer Clinic at the Princess Margaret Cancer Centre.

4) Dr. Alibhai's graduate students are examining a variety of cancer-related issues, including the role of active surveillance in men with prostate cancer, the value of exercise and wearable technology in reducing sedentary behaviour and improving fatigue in people with cancer, and implementation of geriatric assessment in older adults with cancer in Canada.

For a list of Dr. Alibhai's publications, please visit PubMed or Scopus.

Staff Physician, Division of General Internal Medicine and Geriatrics, Mount Sinai Hospital
Associate Professor, Department of Medicine, the Institute of Health Policy, Management, and Evaluation, and the Institute of Medical Sciences, University of Toronto
Research Scientist, Canadian Cancer Society